Sign in

CIK 0001819253

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

biote Corp.

Sign in to watch
Ticker
BTMD
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Entity type
Operating
EIN
851791125
Phone
+1 972-486-9346
Business address
1875 W. WALNUT HILL LN #100, IRVING, TX, 75038
Former names
Haymaker Acquisition Corp. III
  1. 4 Open-market buy 10% owner bought 447,714 shares at an average $3.26 ($1,461,373)
  2. 4 Open-market buy 10% owner bought 1,933 shares at $3.30 ($6,371)
  3. 4 Open-market buy 10% owner bought 8,801 shares at $3.27 ($28,782)
  4. 4 Open-market buy 10% owner bought 7,874 shares at an average $3.29 ($25,906)
  5. 4 Open-market buy 10% owner bought 48,439 shares at an average $3.21 ($155,388)
  6. 4 Open-market buy 10% owner bought 74,440 shares at an average $3.19 ($237,406)
  7. 4/A Open-market buy 10% owner bought 856,609 shares at an average $3.25 ($2,784,419)
  8. 4 Open-market buy 10% owner bought 106,000 shares at $3.32 ($351,920)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Director bought 75,000 shares at an average $3.95 ($296,043)
  13. 4 Open-market buy Chief Executive Officer bought 37,595 shares at $3.87 ($145,493)
  14. 4 Open-market buy Director bought 38,104 shares at $3.88 ($147,844)
  15. 4 Open-market buy Director bought 107,794 shares at $3.87 ($417,163)
  16. 4 Open-market buy 10% owner bought 856,609 shares at an average $3.25 ($2,784,419)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale Chief Financial Officer sold 32,874 shares at $6.20 ($203,848)
  20. 4 Open-market sale Chief Financial Officer sold 11,376 shares at $7.57 ($86,084)

Page 2 of 7 · 138 filings